search
Back to results

Vaginally Assisted Laparoscopic Sacropolpopexy (VALS)

Primary Purpose

Pelvic Organ Prolapse

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Vaginally assisted laparoscopic sacrocolpopexy
Sponsored by
Bezmialem Vakif University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pelvic Organ Prolapse

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

- Women suffering from prolapse and who desired surgical correction of their prolapse were included to trial.

Exclusion Criteria:

- Fertile women who have not completed their family and women with previous POP surgery, POP stage ≤ 2 and women who prefer conservative management or uterus sparing surgery were excluded from the study.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    VALS

    AS

    Arm Description

    Vaginally asissted laparoscopic sacrocolpopexy

    Abdominal Sacrocolpopexy

    Outcomes

    Primary Outcome Measures

    Middle term failure
    stage II or greater apical prolapse, with the leading edge of the C point to 1 cm on either side of the introitus that requires surgical treatment

    Secondary Outcome Measures

    anatomic failure
    as stage II or greater pelvic organ prolapse, with the leading edge of the prolapse to 1 cm on either side of the introitus
    subjective failure
    Subjective failure defined as, if the patients responses were "no change" and "minimally/much worse" in Patient Global Impression of Improvement (PGI-I) which used to assess the outcome of surgical treatment

    Full Information

    First Posted
    March 31, 2020
    Last Updated
    March 31, 2020
    Sponsor
    Bezmialem Vakif University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04332315
    Brief Title
    Vaginally Assisted Laparoscopic Sacropolpopexy
    Acronym
    VALS
    Official Title
    Short and Middle Term Results of Vaginally Assisted Laparoscopic Sacropolpopexy
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    March 2020
    Overall Recruitment Status
    Completed
    Study Start Date
    July 1, 2015 (Actual)
    Primary Completion Date
    February 1, 2020 (Actual)
    Study Completion Date
    March 30, 2020 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Bezmialem Vakif University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Introduction and Hypothesis: Vaginally assisted laparoscopic sacrocolpopexy (VALS), which is a combined surgical approach where a vaginal hysterectomy is initially performed, followed by transvaginal placement of synthetic mesh and laparoscopic suspension, can be an alternative to overcome the dissection, suturing limitations of laparoscopic sacrocolpopexy. The aim of this study was to compare the middle term anatomic outcomes, complication rates, and operative times of patients with uterovaginal prolapse undergoing VALS with those of women undergoing abdominal sacrocolpopexy. Methods: This is a prospective cohort study that evaluates operation times, anesthesia times, estimated blood loss, middle term outcomes, perioperative and postoperative complications. We compared the results of 47 women who had the VALS to that of 32 abdominal sacrocolpopexy.
    Detailed Description
    This is a prospective cohort study comparing VALS method to AS with concurrent hysterectomy in patients advanced symptomatic utero vaginal prolapse stage 3 or 4 according to Pelvic Organ Prolapse Quantification (POP-Q) system. This study was carried out from July 2015 to December 2018. Women suffering from prolapse and who desired surgical correction of their prolapse were included to trial. Fertile women who have not completed their family and women with previous POP surgery, POP stage ≤ 2 and women who prefer conservative management or uterus sparing surgery were excluded from the study. Written informed consent was obtained from all patients before enrolment. This study was approved by the institutional review board. Demographic data including age at surgery, parity, menopausal status, body mass index (BMI), previous pelvic surgeries (hysterectomy, pelvic floor repair, etc.), and comorbidities were obtained from the patient's medical records. Operations: The VALS procedure consists of two steps. First, vaginal hysterectomy or laparoscopically assisted vaginal hysterectomy performed, anterior vaginal wall dissected up to bladder neck starting from initial vaginal incision, posterior vaginal wall dissected from rectum starting from initial vaginal incision up to distal third of posterior vaginal wall. At this step, eversion of the vaginal walls with the aid of surgeon's fingers would facilitate dissection sharply or bluntly. Two hand-sewn, 15 cm long, 3 cm width type 1 polypropylene meshes transfixed to anterior and posterior vaginal wall with 4-6 polyglactin suture to each wall. The free arms of fixed meshes are introduced to the peritoneal cavity and the vaginal vault is closed with absorbable polyglactin suture. Mid urethral sling and/or perineoplasty were performed vaginally before laparoscopy. After changing gloves of surgery team and setting of endoscopy unit, laparoscopy phase was performed with one intraumbilical (10 mm), 3 lateral abdominal (5 mm) trocars. The sacral promontory is identified and the overlying peritoneum is opened up to vaginal cuff laterally to the rectum and medially to the right uterosacral ligament. Two mesh strips fixated to anterior longitudinal ligament of the sacrum with two separate no: 1 polypropylene sutures without tension. The mesh was then peritonealized with absorbable interrupted extracorporeal sutures. AS was performed via Pfannenstiel incision after total or subtotal abdominal hysterectomy was performed regarding the surgeon's choice or presence of cervical pathology. Sacrocolpopexy was performed similar to laparoscopic sacrocolpopexy. The rectosigmoid colon was reflected to the left of the midline to expose the presacral area. The sacral promontory is identified and the overlying peritoneum is opened vertically with scissors by sharp dissection up to vaginal cuff laterally to the rectum and medially to the right uterosacral ligament. After placing a sponge stick or sizer to vagina for manipulation and easy identification of dissection plane, anterior vaginal wall dissected from bladder and posterior vaginal wall dissected from rectum. The surgeon has decided the limit of anterior and posterior vaginal wall dissection. The type 1 polyprolene mesh cut and attached with polyprolpelene suture in a Y formation, typically with 5 cm arm length, 3 cm width and 15-18 cm total length. The appropriate length for each patient is determined intraoperatively. The arms of mesh transfixed to anterior and posterior vaginal wall with 4-6 polyglactin suture to each wall starting from distally. Long arm of mesh fixated to anterior longitudinal ligament of the sacrum with two separate no: 1 polypropylene sutures without tension. The excess mesh parts were trimmed over the sacral promontory after the fixation. The mesh was then reperitonealized with absorbable sutures. We recorded operation times, anesthesia time, additional procedures time, estimated blood loss, outcomes, perioperative and postoperative complications. Anesthesia time began with the anesthetic induction and ended with recovering from anesthesia and transfer of patient to recovery room, including positioning, skin preparation, covering and surgical equipment set up. The total operating time began with the first skin incision and ended with the last closure of an incision. Exclusive operation time of index procedures was calculated by subtracting the additional surgery time from the total operation time. Early complications were defined as any complication that occurred during surgery or within 4 weeks postoperatively including injury to the bladder, bowel, vagina, ureters, or vessels; wound complications; hematoma, abscess, urinary tract infection, gluteal pain, ileus, blood transfusion, and mesh infection. Late complications described any complications occurred during the entire follow-up period after 4 weeks such as; mesh exposition, mesh extrusion mesh perforation, ileus, dyspareunia, vesicovaginal fistul, rectovaginal fistul, ureter obstruction or fistulization. Postoperatively, subjects were evaluated for subjective and anatomic outcomes of the operations by vaginal examination at 1 week and 1, 3, and 12months, every years after surgery. Recurrence was defined as stage II or greater apical prolapse, with the leading edge of the C point to 1 cm on either side of the introitus that requires surgical treatment. Objective failure was defined as stage II or greater pelvic organ prolapse, with the leading edge of the prolapse to 1 cm on either side of the introitus. Subjective failure defined as, if the patients responses were "no change" and "minimally/much worse" in Patient Global Impression of Improvement (PGI-I) which used to assess the outcome of surgical treatment [10]. Statistical analysis was performed after normality testing (histogram analysis and/or Kolmogorov-Smirnov testing) using IBM SPSS, version 21 (IBM Inc., Armonk, NY). The student's t-test was used for comparisons of normally distributed variables, the Mann-Whitney U-test was used for non parametric variables, χ2 test and Fisher's exact tests were used to compare categorical variables. A sample size calculation was performed by using data from von Pechman's pilot study assuming that expected difference in means 0.0, standart deviation is 1.3 from LAS study which compares laparoscopic and open sacrocolpopexy [9, 11]. A sample size of 27 for each group was calculated based on these data, 0.05, one-sided t test was estimated to have 80% power to reject the null hypothesis that the VALS and AS techniques are not equivalent.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Pelvic Organ Prolapse

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Non-Randomized
    Enrollment
    87 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    VALS
    Arm Type
    Active Comparator
    Arm Description
    Vaginally asissted laparoscopic sacrocolpopexy
    Arm Title
    AS
    Arm Type
    Active Comparator
    Arm Description
    Abdominal Sacrocolpopexy
    Intervention Type
    Procedure
    Intervention Name(s)
    Vaginally assisted laparoscopic sacrocolpopexy
    Other Intervention Name(s)
    Abdominal sacrocolpopexy
    Intervention Description
    The VALS procedure consists of two steps. First, vaginal hysterectomy or laparoscopically assisted vaginal hysterectomy performed, anterior vaginal wall dissected up to bladder neck starting from initial vaginal incision, posterior vaginal wall dissected from rectum starting from initial vaginal incision up to distal third of posterior vaginal wall.The free arms of fixed meshes are introduced to the peritoneal cavity and the vaginal vault is closed with absorbable polyglactin suture. laparoscopy phase was performed with one intraumbilical (10 mm), 3 lateral abdominal (5 mm) trocars. Two mesh strips fixated to anterior longitudinal ligament of the sacrum with two separate no: 1 polypropylene sutures without tension. AS was performed via Pfannenstiel incision after total or subtotal abdominal hysterectomy
    Primary Outcome Measure Information:
    Title
    Middle term failure
    Description
    stage II or greater apical prolapse, with the leading edge of the C point to 1 cm on either side of the introitus that requires surgical treatment
    Time Frame
    2 years
    Secondary Outcome Measure Information:
    Title
    anatomic failure
    Description
    as stage II or greater pelvic organ prolapse, with the leading edge of the prolapse to 1 cm on either side of the introitus
    Time Frame
    2 years
    Title
    subjective failure
    Description
    Subjective failure defined as, if the patients responses were "no change" and "minimally/much worse" in Patient Global Impression of Improvement (PGI-I) which used to assess the outcome of surgical treatment
    Time Frame
    2 years

    10. Eligibility

    Sex
    Female
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    80 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: - Women suffering from prolapse and who desired surgical correction of their prolapse were included to trial. Exclusion Criteria: - Fertile women who have not completed their family and women with previous POP surgery, POP stage ≤ 2 and women who prefer conservative management or uterus sparing surgery were excluded from the study.

    12. IPD Sharing Statement

    Learn more about this trial

    Vaginally Assisted Laparoscopic Sacropolpopexy

    We'll reach out to this number within 24 hrs